Biomea Fusion Inc. (BMEA)
NASDAQ: BMEAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 1.35 +2.15%
BMEA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $95.44M
- EPS (TTM)
- -$0.29
- Dividend yield
- None
- 52-week range
- 0.872 – 2.24
- Day range
- 1.25 – 1.34
- Volume / Avg
- 821.04K / 1.49M
- Beta
- —
- Shares outstanding
- 72.30M
- Next earnings
- Nov 3, 2026
52-week range
BMEA stock today
Biomea Fusion (BMEA) closed at $1.32 on Oct 7, up 5.60% (+$0.07), versus the S&P 500's 0.22% decline. Shares are 41.0% below their 52-week high of $2.24, set on Apr 20, 2026 and 51.4% above the 52-week low of $0.872, in the middle of the past year's range. BMEA is up 6.5% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 28.5%.
Biomea Fusion has posted a net loss over the last twelve months (EPS of -$0.29), so its P/E ratio is not meaningful. Biomea Fusion's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Biomea Fusion
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 3, 2026
- EPS estimate
- $-0.21
Biomea Fusion peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| OKUROnKure Therapeutics Inc. Class A | 2.35 | -4.47% | $95.17M | vs BMEA |
| MISTMilestone Pharmaceuticals Inc. | 0.7572 | -0.92% | $94.27M | vs BMEA |
| CTORCitius Oncology Inc. | 0.851 | +0.12% | $90.00M | vs BMEA |
| RLYBRallybio Corporation | 16.93 | -0.88% | $89.94M | vs BMEA |
| ANIXAnixa Biosciences Inc. | 2.95 | -2.32% | $102.55M | vs BMEA |
| EQEquillium Inc. | 1.39 | -2.11% | $88.14M | vs BMEA |
| CPIXCumberland Pharmaceuticals Inc. | 6.89 | -3.50% | $103.23M | vs BMEA |
| IMUXImmunic Inc. | 7.63 | -2.43% | $104.11M | vs BMEA |
Indexes, lists and sector
Biomea Fusion stock FAQ
What is Biomea Fusion's stock price today?
BMEA last traded at $1.32 as of Oct 7, 4:00 PM EDT, up 5.60% on the day. Prices are delayed at least 15 minutes.
When is Biomea Fusion's next earnings date?
Biomea Fusion is expected to report earnings on Tuesday, November 3, 2026. Analysts expect EPS of $-0.21.
What is the BMEA 52-week high?
The 52-week high for BMEA is $2.24 and the 52-week low is $0.872. The stock is currently 41.0% below its high.